Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00384800
Status:
UNKNOWN
Last Update Posted:
2009-02-09
First Post:
2006-10-04
Brief Title:
A Phase II Study of TegafurUracil UFURPlus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma HCC
Sponsor:
Far Eastern Memorial Hospital
Organization:
Far Eastern Memorial Hospital
Organization Data
Organization:
Far Eastern Memorial Hospital
Class:
OTHER
Study ID:
FEMH-94037
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Far Eastern Memorial Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Far Eastern Memorial Hospital
Old Organization:
Far Eastern Memorial Hospital